KEMCO

Smartkem shares are trading lower. The company announced a non-binding letter of intent to acquire all outstanding shares of Carbonium Core in exchange for shares of Smartkem Series B Convertible Preferred Stock.

100+ Kemps workers in Farmington strike over pay, benefits

DFA Teamsters Authorize Strike at Kemps

Jim Cramer: Eli Lilly Is A 'Good Company,' But Doesn't 'Really Care For' This Quantum Stock

CNBC's Mad Money Lightning Round: Cramer says Astera Labs (ALAB) is a buy, but doesn't care for Rigetti Computing (RGTI). Eli Lilly (LLY) is a classic own, don't trade. MakeMyTrip (MMYT) coverage initiated with Buy rating.

ALABAMA POWER ANNOUNCES ADDITIONS TO BOARD OF DIRECTORS

Tom Hand and Mike Kemp, Sr. have been elected to the Alabama Power Board of Directors.

AbbVie Inc. (ABBV) Hits New Milestone with Venetoclax on Chronic Lymphocytic Leukemia (CLL) Treatment

AbbVie Inc. (NYSE:ABBV) is one of the best dividend aristocrat stocks to buy now. On June 19, AbbVie Inc. (NYSE:ABBV) delivered topline Phase 3 data on a fixed-duration venetoclax-based combination at the European Hematology Association (EHA) 2026 Congress. The results from the Phase 3 CLL14 trial affirm venetoclax’s enduring safety and efficacy in untreated chronic […]

Blakeman slams Lander in TV interview over Israel stance

Eastman Expands Portfolio With Jarylec Dielectric Fluids Buyout

EMN expands in dielectric fluids with Jarylec acquisition, adding assets from Arkema and strengthening its power grid applications portfolio.

Trump-endorsed Collins beats Kemp’s pick to take on Ossoff for Georgia Senate

Eli Lilly (LLY) Buys 4E Therapeutics As Jaypirca Hits Key Leukemia Milestone

Eli Lilly (NYSE:LLY) is acquiring 4E Therapeutics, adding MNK inhibitor candidates aimed at non opioid chronic pain treatment. The deal expands Lilly's neuroscience pipeline beyond its existing focus on metabolic and diabetes therapies. Jaypirca has reached a key clinical milestone in the Phase 3 BRUIN CLL-322 trial in relapsed or refractory chronic lymphocytic leukemia when used with venetoclax and rituximab. These developments represent fresh, material updates for Eli Lilly that relate...